JOHN VIERLING to Hepatic Encephalopathy
This is a "connection" page, showing publications JOHN VIERLING has written about Hepatic Encephalopathy.
Connection Strength
1.379
-
Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016 06; 14(6):903-906.e1.
Score: 0.454
-
Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy. Clin Liver Dis. 2015 Aug; 19(3):577-89.
Score: 0.442
-
Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy. Dig Dis Sci. 2016 06; 61(6):1728-34.
Score: 0.114
-
Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure. Hepatology. 1995 Nov; 22(5):1379-86.
Score: 0.113
-
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014 Mar; 59(3):1073-83.
Score: 0.100
-
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab. 2013 Dec; 110(4):446-53.
Score: 0.098
-
Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transplant Proc. 1997 Feb-Mar; 29(1-2):487-8.
Score: 0.031
-
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S128-36.
Score: 0.015
-
Hepatic injury by prescription medication. Med Sect Proc. 1983; 79-86.
Score: 0.012